FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162599155> ?p ?o ?g. }

• W2162599155 endingPage "97" @default.
• W2162599155 startingPage "91" @default.
• W2162599155 abstract "We assessed the effects of felbamate (FBM) on the disposition of valpr oic acid (VPA) in healthy volunteer men. Eighteen subjects received sodium VPA, 400 mg/day for 21 days. Plasma and urine samples were taken on day 7 to document the steady-state disposition of VPA alone. From day 8 to day 21, subjects received placebo or FBM at the following doses (mg/day): 1,200, 2,400, 3,000, or 3,600 (n = 2-4 per group). Many adverse events (AE) occurred from about day 10; 2 subjects dropped out and 1 continued on a reduced FBM dose. Pharmacokinetic studies were repeated on day 21 for the 16 subjects who completed the study. FBM was measured in plasma and urine by high-performance liquid chromatography (HPLC). VPA and its 2-en, 4-en, and 3-oxo metabolites in plasma, and VPA (nonconjugated and total), and its 3-oxo and 4-hydroxy metabolites in urine were measured by gas chromatography/mass spectrometry (GC/MS). Mean plasma FBM trough concentrations on day 21 ranged from 26.9 mu g/ml (1,200 mg dose) to 76.8 mu g/ml (3,600-mg dose). Mean plasma VPA C max values were 32-42 mu g/ml in the various subgroups when VPA only was administered. Higher plasma VPA levels were observed when FBM was administered concurrently (55.4-63.8 mu g/ml). The excretion of 3-oxo-VPA in urine was significantly lower on day 21 than on day 7, whereas VPA-glucuronide was significantly increased. The effects of FBM on VPA disposition were dose dependent and were maximal at approximately 2400 mg/day. FBM has caused significant inhibition of the beta-oxidation pathway for VPA metabolic clearance, and this had been largely compensated by increased VPA glucuronidation." @default.
• W2162599155 created "2016-06-24" @default.
• W2162599155 creator A5008637720 @default.
• W2162599155 creator A5013466966 @default.
• W2162599155 creator A5022110262 @default.
• W2162599155 creator A5038107882 @default.
• W2162599155 creator A5041684054 @default.
• W2162599155 creator A5050833432 @default.
• W2162599155 creator A5052099914 @default.
• W2162599155 creator A5073909248 @default.
• W2162599155 creator A5077856680 @default.
• W2162599155 date "1996-01-01" @default.
• W2162599155 modified "2023-09-27" @default.
• W2162599155 title "Effect of Felbamate on Valproic Acid Disposition in Healthy Volunteers: Inhibition of beta-Oxidation" @default.
• W2162599155 cites W1966731879 @default.
• W2162599155 cites W1990805037 @default.
• W2162599155 cites W2010272426 @default.
• W2162599155 cites W2015075315 @default.
• W2162599155 cites W2024340666 @default.
• W2162599155 cites W2073476496 @default.
• W2162599155 cites W2083969921 @default.
• W2162599155 cites W2133518076 @default.
• W2162599155 cites W2151908629 @default.
• W2162599155 cites W2502670554 @default.
• W2162599155 doi "https://doi.org/10.1111/j.1528-1157.1996.tb00518.x" @default.
• W2162599155 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8603632" @default.
• W2162599155 hasPublicationYear "1996" @default.
• W2162599155 type Work @default.
• W2162599155 sameAs 2162599155 @default.
• W2162599155 citedByCount "56" @default.
• W2162599155 countsByYear W21625991552013 @default.
• W2162599155 countsByYear W21625991552014 @default.
• W2162599155 countsByYear W21625991552015 @default.
• W2162599155 countsByYear W21625991552016 @default.
• W2162599155 countsByYear W21625991552017 @default.
• W2162599155 countsByYear W21625991552019 @default.
• W2162599155 countsByYear W21625991552021 @default.
• W2162599155 countsByYear W21625991552022 @default.
• W2162599155 crossrefType "journal-article" @default.
• W2162599155 hasAuthorship W2162599155A5008637720 @default.
• W2162599155 hasAuthorship W2162599155A5013466966 @default.
• W2162599155 hasAuthorship W2162599155A5022110262 @default.
• W2162599155 hasAuthorship W2162599155A5038107882 @default.
• W2162599155 hasAuthorship W2162599155A5041684054 @default.
• W2162599155 hasAuthorship W2162599155A5050833432 @default.
• W2162599155 hasAuthorship W2162599155A5052099914 @default.
• W2162599155 hasAuthorship W2162599155A5073909248 @default.
• W2162599155 hasAuthorship W2162599155A5077856680 @default.
• W2162599155 hasConcept C112705442 @default.
• W2162599155 hasConcept C118552586 @default.
• W2162599155 hasConcept C142724271 @default.
• W2162599155 hasConcept C179998833 @default.
• W2162599155 hasConcept C185592680 @default.
• W2162599155 hasConcept C204787440 @default.
• W2162599155 hasConcept C27081682 @default.
• W2162599155 hasConcept C2775858608 @default.
• W2162599155 hasConcept C2776768635 @default.
• W2162599155 hasConcept C2777172819 @default.
• W2162599155 hasConcept C2777477808 @default.
• W2162599155 hasConcept C2778186239 @default.
• W2162599155 hasConcept C2779186261 @default.
• W2162599155 hasConcept C2780026642 @default.
• W2162599155 hasConcept C2781011581 @default.
• W2162599155 hasConcept C43617362 @default.
• W2162599155 hasConcept C55493867 @default.
• W2162599155 hasConcept C6557445 @default.
• W2162599155 hasConcept C71924100 @default.
• W2162599155 hasConcept C86803240 @default.
• W2162599155 hasConcept C98274493 @default.
• W2162599155 hasConceptScore W2162599155C112705442 @default.
• W2162599155 hasConceptScore W2162599155C118552586 @default.
• W2162599155 hasConceptScore W2162599155C142724271 @default.
• W2162599155 hasConceptScore W2162599155C179998833 @default.
• W2162599155 hasConceptScore W2162599155C185592680 @default.
• W2162599155 hasConceptScore W2162599155C204787440 @default.
• W2162599155 hasConceptScore W2162599155C27081682 @default.
• W2162599155 hasConceptScore W2162599155C2775858608 @default.
• W2162599155 hasConceptScore W2162599155C2776768635 @default.
• W2162599155 hasConceptScore W2162599155C2777172819 @default.
• W2162599155 hasConceptScore W2162599155C2777477808 @default.
• W2162599155 hasConceptScore W2162599155C2778186239 @default.
• W2162599155 hasConceptScore W2162599155C2779186261 @default.
• W2162599155 hasConceptScore W2162599155C2780026642 @default.
• W2162599155 hasConceptScore W2162599155C2781011581 @default.
• W2162599155 hasConceptScore W2162599155C43617362 @default.
• W2162599155 hasConceptScore W2162599155C55493867 @default.
• W2162599155 hasConceptScore W2162599155C6557445 @default.
• W2162599155 hasConceptScore W2162599155C71924100 @default.
• W2162599155 hasConceptScore W2162599155C86803240 @default.
• W2162599155 hasConceptScore W2162599155C98274493 @default.
• W2162599155 hasIssue "1" @default.
• W2162599155 hasLocation W21625991551 @default.
• W2162599155 hasLocation W21625991552 @default.
• W2162599155 hasOpenAccess W2162599155 @default.
• W2162599155 hasPrimaryLocation W21625991551 @default.
• W2162599155 hasRelatedWork W1964650076 @default.
• W2162599155 hasRelatedWork W1964759623 @default.
• W2162599155 hasRelatedWork W2027216937 @default.

• next